Deal sells 876,042 units of one share, one warrant at $1.50 per unit
By Devika Patel
Knoxville, Tenn., March 30 - RepliCel Life Sciences Inc. said it settled a $1.31 million private placement of units. An initial tranche of $99,456 closed on Feb. 29.
The company sold 876,042 units of one common share and a warrant at $1.50 per unit. It sold 66,304 units in the first tranche.
Each two-year warrant is exercisable at $2.50, which represents an 11.11% premium to the Feb. 28 closing share price of $2.25.
RepliCel is a Vancouver, B.C.-based company that is developing an anti-balding technology.
| Issuer: | RepliCel Life Sciences Inc.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | $1,314,063
|
| Units: | 876,042
|
| Price: | $1.50
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Two years
|
| Warrant strike price: | $2.50
|
| Announcement date: | March 30
|
| Settlement dates: | Feb. 29 (for $99,456), March 30
|
| Stock symbol: | OTCBB: REPCF
|
| Stock price: | $2.25 at close Feb. 28
|
| Market capitalization: | $84.14 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
